24.70
price down icon2.56%   -0.65
after-market アフターアワーズ: 24.78 0.08 +0.32%
loading
前日終値:
$25.35
開ける:
$25.44
24時間の取引高:
8.71M
Relative Volume:
0.86
時価総額:
$9.61B
収益:
$3.14B
当期純損益:
$-3.36B
株価収益率:
-2.8293
EPS:
-8.73
ネットキャッシュフロー:
$-4.03B
1週間 パフォーマンス:
-8.01%
1か月 パフォーマンス:
-2.49%
6か月 パフォーマンス:
-11.21%
1年 パフォーマンス:
-55.27%
1日の値動き範囲:
Value
$24.41
$25.55
1週間の範囲:
Value
$24.41
$27.37
52週間の値動き範囲:
Value
$23.15
$56.70

Moderna Inc Stock (MRNA) Company Profile

Name
名前
Moderna Inc
Name
セクター
Healthcare (1136)
Name
電話
(617) 714-6500
Name
住所
325 BINNEY STREET, CAMBRIDGE
Name
職員
5,800
Name
Twitter
@moderna_tx
Name
次回の収益日
2025-08-01
Name
最新のSEC提出書
Name
MRNA's Discussions on Twitter

MRNA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MRNA
Moderna Inc
24.70 9.90B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.21 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
652.91 69.37B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.59 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
821.97 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
166.95 34.94B 398.11M -1.03B -868.57M -5.7032

Moderna Inc Stock (MRNA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-13 開始されました Citigroup Neutral
2025-02-18 ダウングレード Barclays Overweight → Equal Weight
2025-01-29 ダウングレード Goldman Buy → Neutral
2024-12-18 ダウングレード Argus Buy → Hold
2024-12-10 再開されました BofA Securities Underperform
2024-11-19 開始されました Berenberg Hold
2024-11-18 アップグレード HSBC Securities Hold → Buy
2024-11-15 開始されました Wolfe Research Underperform
2024-10-17 開始されました Bernstein Mkt Perform
2024-09-13 ダウングレード JP Morgan Neutral → Underweight
2024-09-13 ダウングレード Jefferies Buy → Hold
2024-09-13 ダウングレード Oppenheimer Outperform → Perform
2024-08-28 アップグレード HSBC Securities Reduce → Hold
2024-08-07 アップグレード Deutsche Bank Sell → Hold
2024-08-05 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-02-26 ダウングレード HSBC Securities Hold → Reduce
2024-01-02 アップグレード Oppenheimer Perform → Outperform
2023-11-29 開始されました Canaccord Genuity Hold
2023-11-03 アップグレード HSBC Securities Reduce → Hold
2023-11-02 ダウングレード Deutsche Bank Hold → Sell
2023-08-04 ダウングレード TD Cowen Outperform → Market Perform
2023-08-03 ダウングレード Deutsche Bank Buy → Hold
2023-07-24 開始されました William Blair Mkt Perform
2023-07-14 開始されました HSBC Securities Reduce
2023-06-26 アップグレード UBS Neutral → Buy
2023-04-26 開始されました Guggenheim Neutral
2023-03-13 アップグレード TD Cowen Market Perform → Outperform
2023-03-02 開始されました RBC Capital Mkts Outperform
2023-02-24 ダウングレード SVB Securities Market Perform → Underperform
2022-12-19 アップグレード Jefferies Hold → Buy
2022-12-14 ダウングレード Chardan Capital Markets Buy → Neutral
2022-10-21 アップグレード SVB Leerink Underperform → Mkt Perform
2022-09-08 アップグレード Deutsche Bank Hold → Buy
2022-02-01 アップグレード Redburn Sell → Neutral
2022-01-26 アップグレード Deutsche Bank Sell → Hold
2022-01-21 アップグレード BofA Securities Underperform → Neutral
2022-01-21 開始されました UBS Neutral
2021-12-07 開始されました Cowen Market Perform
2021-11-09 開始されました Wolfe Research Outperform
2021-10-22 開始されました Deutsche Bank Sell
2021-10-15 アップグレード Piper Sandler Neutral → Overweight
2021-08-06 ダウングレード Oppenheimer Outperform → Perform
2021-08-06 ダウングレード Piper Sandler Overweight → Neutral
2021-07-15 繰り返されました Jefferies Hold
2021-02-01 ダウングレード BofA Securities Neutral → Underperform
2020-12-16 ダウングレード Jefferies Buy → Hold
2020-12-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-09 ダウングレード Needham Buy → Hold
2020-11-23 開始されました Wells Fargo Equal Weight
2020-11-17 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-09-08 ダウングレード SVB Leerink Mkt Perform → Underperform
2020-07-23 開始されました SVB Leerink Mkt Perform
2020-07-20 ダウングレード JP Morgan Overweight → Neutral
2020-07-13 開始されました Jefferies Buy
2020-06-30 開始されました Argus Buy
2020-06-08 開始されました Barclays Overweight
2020-04-30 開始されました BMO Capital Markets Outperform
2020-03-05 ダウングレード BofA/Merrill Buy → Neutral
2019-12-03 再開されました BofA/Merrill Buy
2019-10-25 開始されました ROTH Capital Buy
2019-04-05 開始されました Chardan Capital Markets Buy
すべてを表示

Moderna Inc (MRNA) 最新ニュース

pulisher
Oct 28, 2025

US health agency fires official who opposed mRNA Covid shots - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

New COVID vaccine says it’s for the ‘senior class’ — does it reduce side effects? - San Francisco Chronicle

Oct 28, 2025
pulisher
Oct 28, 2025

AlphaQuest LLC Increases Position in Moderna, Inc. $MRNA - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Ethic Inc. Purchases 10,325 Shares of Moderna, Inc. $MRNA - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

How Moderna Inc. stock trades before earningsWatch List & Community Verified Swing Trade Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Moderna Inc. stock see insider buyingJuly 2025 Breakouts & Verified Momentum Watchlists - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Why Moderna Inc. stock is a value investor pick2025 Retail Activity & Stock Portfolio Risk Management - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Vertex and Moderna’s VX-522 Study: A Potential Breakthrough in Cystic Fibrosis Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Moderna Says Vax Efficacy Math Doesn't Show Investor Fraud - Law360

Oct 27, 2025
pulisher
Oct 27, 2025

What’s next for Moderna Inc. stock priceJuly 2025 Institutional & High Conviction Buy Zone Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Best data tools to analyze Moderna Inc. stockDollar Strength & Growth Oriented Trade Recommendations - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Using economic indicators to assess Moderna Inc. potentialTrade Ideas & Real-Time Price Movement Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Moderna Inc. meeting your algorithmic filter criteriaJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

D.A. Davidson & CO. Purchases 62,778 Shares of Moderna, Inc. $MRNA - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Why Moderna Inc. stock is favored by top institutionsJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Moderna Inc. stock in correction or buying zonePortfolio Return Summary & Long-Term Capital Growth Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Analysts Set Expectations for Moderna FY2026 Earnings - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

FY2026 EPS Estimates for Moderna Lowered by Analyst - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Equities Analysts Issue Forecasts for Moderna Q3 Earnings - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Moderna (NASDAQ:MRNA) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Is it too late to sell Moderna Inc.IPO Watch & Accurate Entry and Exit Point Alerts - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Moderna scraps mRNA vaccine in congenital CMV on trial failure - Medical Dialogues

Oct 26, 2025
pulisher
Oct 25, 2025

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - The Daily News Journal

Oct 25, 2025
pulisher
Oct 25, 2025

VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Moderna, Inc. $MRNA - MarketBeat

Oct 25, 2025
pulisher
Oct 25, 2025

How moving averages guide Moderna Inc. trading2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Moderna to Host Investor Event – Analyst Day - Shelby Star

Oct 25, 2025
pulisher
Oct 25, 2025

Moderna Named a Top Employer by Science for Eleventh Consecutive Year - Bluffton Today

Oct 25, 2025
pulisher
Oct 24, 2025

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism - Pueblo Chieftain

Oct 24, 2025
pulisher
Oct 24, 2025

Moderna (MRNA) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

JPMorgan Chase & Co. Cuts Moderna (NASDAQ:MRNA) Price Target to $25.00 - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Moderna (NASDAQ:MRNA) Shares Gap Down Following Analyst Downgrade - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans - The Daily Jeffersonian

Oct 24, 2025
pulisher
Oct 24, 2025

UBS Maintains Moderna (MRNA) Buy Recommendation - Nasdaq

Oct 24, 2025
pulisher
Oct 24, 2025

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint - The Holland Sentinel

Oct 24, 2025
pulisher
Oct 23, 2025

How Investors May Respond To Moderna (MRNA) Halting Development of mRNA-1647 CMV Vaccine - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories - The Asheville Citizen Times

Oct 23, 2025
pulisher
Oct 23, 2025

Moderna, Inc. (MRNA) Stock Forecasts - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

UBS Adjusts Moderna (MRNA) Price Target to $40, Maintains Buy Ra - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

Moderna’s cytomegalovirus vaccine fails a phase III - BioWorld MedTech

Oct 23, 2025
pulisher
Oct 23, 2025

Moderna Flunks Pivotal CMV Trial, But Read-Through Unlikely - Citeline News & Insights

Oct 23, 2025

Moderna Inc (MRNA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.67
price up icon 0.71%
$90.18
price down icon 1.60%
$28.95
price down icon 0.62%
$103.35
price down icon 1.60%
biotechnology ONC
$314.85
price down icon 0.63%
$166.95
price up icon 1.00%
大文字化:     |  ボリューム (24 時間):